Works matching AU Tam, Constantine

Results: 175
    1

    Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era.

    Published in:
    Internal Medicine Journal, 2025, v. 55, n. 7, p. 1105, doi. 10.1111/imj.70050
    By:
    • Barge, Luani;
    • Tran, Steven;
    • Kennedy, Glen;
    • Ritchie, David;
    • Gottlieb, David;
    • Milliken, Sam;
    • Spencer, Andrew;
    • Purtill, Duncan;
    • Perera, Travis;
    • Doocey, Richard;
    • Larsen, Stephen;
    • Butler, Andrew;
    • Bardy, Peter;
    • Greenwood, Matthew;
    • Durrant, Simon;
    • Curley, Cameron;
    • Stewart, Caroline;
    • Tam, Constantine;
    • Balendran, Shalini;
    • Di Ciaccio, Pietro R.
    Publication type:
    Article
    2
    3
    4

    Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy.

    Published in:
    EJHaem, 2024, v. 5, n. 5, p. 929, doi. 10.1002/jha2.1013
    By:
    • Lamanna, Nicole;
    • Tam, Constantine S.;
    • Woyach, Jennifer A.;
    • Alencar, Alvaro J.;
    • Palomba, M. Lia;
    • Zinzani, Pier Luigi;
    • Flinn, Ian W.;
    • Fakhri, Bita;
    • Cohen, Jonathon B.;
    • Kontos, Arrin;
    • Konig, Heiko;
    • Ruppert, Amy S.;
    • Chatterjee, Anindya;
    • Sizelove, Richard;
    • Compte, Livia;
    • Tsai, Donald E.;
    • Jurczak, Wojciech
    Publication type:
    Article
    5
    6

    Prospective comprehensive profiling of immune responses to COVID‐19 vaccination in patients on zanubrutinib therapy.

    Published in:
    EJHaem, 2023, v. 4, n. 1, p. 216, doi. 10.1002/jha2.639
    By:
    • Nguyen, Thi H. O.;
    • Lim, Chhay;
    • Lasica, Masa;
    • Whitechurch, Ashley;
    • Tennakoon, Surekha;
    • Saunders, Natalie R.;
    • Allen, Lilith F.;
    • Rowntree, Louise C.;
    • Chua, Brendon Y.;
    • Kedzierski, Lukasz;
    • Tan, Hyon‐Xhi;
    • Wheatley, Adam K.;
    • Kent, Stephen J.;
    • Karapanagiotidis, Theo;
    • Nicholson, Suellen;
    • Williamson, Deborah A.;
    • Slavin, Monica A.;
    • Tam, Constantine S.;
    • Kedzierska, Katherine;
    • Teh, Benjamin W.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 12, p. 1353, doi. 10.1002/ajh.25638
    By:
    • Munir, Talha;
    • Brown, Jennifer R.;
    • O'Brien, Susan;
    • Barrientos, Jacqueline C.;
    • Barr, Paul M.;
    • Reddy, Nishitha M.;
    • Coutre, Steven;
    • Tam, Constantine S.;
    • Mulligan, Stephen P.;
    • Jaeger, Ulrich;
    • Kipps, Thomas J.;
    • Moreno, Carol;
    • Montillo, Marco;
    • Burger, Jan A.;
    • Byrd, John C.;
    • Hillmen, Peter;
    • Dai, Sandra;
    • Szoke, Anita;
    • Dean, James P.;
    • Woyach, Jennifer A.
    Publication type:
    Article
    16

    Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1394, doi. 10.1002/ajh.25261
    By:
    • Mato, Anthony R.;
    • Roeker, Lindsey E.;
    • Allan, John N.;
    • Pagel, John M.;
    • Brander, Danielle M.;
    • Hill, Brian T.;
    • Cheson, Bruce D.;
    • Furman, Richard R.;
    • Lamanna, Nicole;
    • Tam, Constantine S.;
    • Handunnetti, Sasanka;
    • Jacobs, Ryan;
    • Lansigan, Frederick;
    • Bhavsar, Erica;
    • Barr, Paul M.;
    • Shadman, Mazyar;
    • Skarbnik, Alan P.;
    • Goy, Andre;
    • Beach, Douglas F.;
    • Svoboda, Jakub
    Publication type:
    Article
    17

    Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 11, p. 967, doi. 10.1002/ajh.24125
    By:
    • Stephens, Deborah M.;
    • Ruppert, Amy S.;
    • Weirda, William G.;
    • Jones, Jeffrey A.;
    • Woyach, Jennifer A.;
    • Maddocks, Kami;
    • Jaglowski, Samantha M.;
    • Andritsos, Leslie A.;
    • Flynn, Joseph M.;
    • Grever, Michael R.;
    • Lozanski, Gerard;
    • Tam, Constantine;
    • O'Brien, Susan;
    • Keating, Michael J.;
    • Muthusamy, Natarajan;
    • Abruzzo, Lynne V.;
    • Heerema, Nyla A.;
    • Byrd, John C.
    Publication type:
    Article
    18

    Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 22, p. 8468, doi. 10.1002/cam4.3470
    By:
    • Cuneo, Antonio;
    • Mato, Anthony R.;
    • Rigolin, Gian Matteo;
    • Piciocchi, Alfonso;
    • Gentile, Massimo;
    • Laurenti, Luca;
    • Allan, John N.;
    • Pagel, John M.;
    • Brander, Danielle M.;
    • Hill, Brian T.;
    • Winter, Allison;
    • Lamanna, Nicole;
    • Tam, Constantine S.;
    • Jacobs, Ryan;
    • Lansigan, Frederick;
    • Barr, Paul M.;
    • Shadman, Mazyar;
    • Skarbnik, Alan P.;
    • Pu, Jeffrey J.;
    • Sehgal, Alison R.
    Publication type:
    Article
    19
    20

    Zanubrutinib: past, present, and future.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00902-x
    By:
    • Tam, Constantine S.;
    • Muñoz, Javier L.;
    • Seymour, John F.;
    • Opat, Stephen
    Publication type:
    Article
    21
    22

    Zanubrutinib: past, present, and future.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00902-x
    By:
    • Tam, Constantine S.;
    • Muñoz, Javier L.;
    • Seymour, John F.;
    • Opat, Stephen
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    P1679: HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG‐TERM FOLLOW‐UP.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000973588.27391.ea
    By:
    • Tedeschi, Alessandra;
    • Tam, Constantine;
    • Owen, Roger;
    • Buske, Christian;
    • Leblond, Véronique;
    • Dimopoulos, Meletios A.;
    • García‐Sanz, Ramón;
    • Castillo, Jorge;
    • Trotman, Judith;
    • Treon, Steven;
    • Yang, Keri;
    • Tang, Boxiong;
    • Allewelt, Heather;
    • Patel, Sheel;
    • Chan, Wai;
    • Cohen, Aileen;
    • Schneider, Jingjing Yan;
    • Barnes, Gisoo
    Publication type:
    Article
    41
    42
    43

    P1108: EFFICACY OF PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: RESULTS FROM THE PHASE 1/2 BRUIN STUDY.

    Published in:
    2023
    By:
    • Scarfò, Lydia;
    • Patel, Manish R.;
    • Eyre, Toby A.;
    • Jurczak, Wojciech;
    • Lewis, David;
    • Gastinne, Thomas;
    • MA, Shuo;
    • Cohen, Jonathon B.;
    • Patel, Krish;
    • Brown, Jennifer R.;
    • Munir, Talha;
    • Lech-Maranda, Ewa;
    • Hoffmann, Marc S.;
    • Ujjani, Chaitra S.;
    • Fakhri, Bita;
    • Wang, Michael;
    • Izutsu, Koji;
    • Nagai, Hirokazu;
    • Tam, Constantine S.;
    • Seymour, John F.
    Publication type:
    Abstract
    44
    45

    P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY PROFILE AND COMPARISON WITH IBRUTINIB PROFILE IN PATIENTS WITH B-CELL MALIGNANCIES: POST HOC ANALYSIS OF A LARGE CLINICAL TRIAL SAFETY DATABASE.

    Published in:
    2023
    By:
    • Brown, Jennifer R.;
    • Eichhorst, Barbara;
    • Ghia, Paolo;
    • Jurczak, Wojciech;
    • Kahl, Brad;
    • Lamanna, Nicole;
    • Robak, Tadeusz;
    • Shadman, Mazyar;
    • Tam, Constantine;
    • Qiu, Lugui;
    • Cohen, Aileen;
    • Zhang, Meng;
    • Salmi, Tommi;
    • Paik, Jason;
    • Wang, Liping;
    • Zhang, Jun;
    • MA, Han;
    • Tedeschi, Alessandra
    Publication type:
    Abstract
    46
    47

    S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY.

    Published in:
    2023
    By:
    • Brown, Jennifer R.;
    • Desikan, Sai Prasad;
    • Nguyen, Bastien;
    • Won, Helen;
    • Tantawy, Shady;
    • Mcneely, Samuel Clark;
    • Marella, Narasimha;
    • Ebata, Kevin;
    • Woyach, Jennifer;
    • Patel, Krish;
    • Tam, Constantine;
    • Eyre, Toby;
    • Cheah, Chan;
    • Shah, Nirav N;
    • Ghia, Paolo;
    • Jurczak, Wojciech;
    • Balbas, Minna;
    • Nair, Binoj;
    • Abada, Paolo;
    • Wang, Chunxiao
    Publication type:
    Abstract
    48
    49
    50